Journal of Pharmaceutical and Biomedical Sciences

Login
Select Language
Subscription Login to verify subscription
Give a gift subscription
Article Tools
Print this article
Indexing metadata
How to cite item
Finding References
Review policy
Email this article (Login required)
Email the author(Login required)
Post a Comment (Login required)

Effects of Shexiang Baoxin Pill and Isosorbide Dinitrate on Angina of Coronary Heart Disease: A Meta-Analysis

Haihua Guo, Guohua Cheng

Abstract


Objective The aim of this study was to evaluate the evidence for Shexiang Baoxin Pill (SBP) and isosorbide dinitrate (ISDN/Xiaoxintong) use in angina of coronary heart disease. We compared their efficacy in effect rate in angina relief (included significant effect and normal effect) and electrocardiogram (EGC) improving rate.
Methods Systematically searched Randomized Control Trials (RCTs) in the Cochrane Library, EMBASE, MEDLINE, PubMed, Wanfang and CNKI databases from 2000 to 2016. According to the Cochrane Handbook for systematic reviews, quality assessment and data extraction were precise. All data were analyzed by using Review Manager 5.3.
Results 26 studies total 2,634 cases were included. In SBP groups, the effect rate and electrocardiogram improving rate are 90.0% (1223/1358) and 78.3% (799/1021), higher to the ISDN 73.6% (939/1276) and 60.2% (571/947). Both of the meta-analysis showed the SBP is the better one [ Total effect: OR = 0.30; 95% CI = 0.24–0.37; ECG improved: OR = 0.30 95% CI = 0.30–0.46].
Conclusion Shexiang Baoxin Pill has a significant effect to the Isosorbide Dinitrate in angina of coronary heart disease.

Keywords


shexiang baoxin pill; SBP; Isosorbide dinitrate; ISDN; coronary heart disease; angina pectoris; meta-analysis; chinese traditional medicine; ECG

Full Text:

References


Ning HH. Efficacy of Shexiang Tongxin Drop pill treating angina pectori.Chin J Geriatric Care. 2012;10:46.

Zheng GH, Xiong SQ, Zhou K, Zhu JF, Wang T, Fu XP. Study on Chinese medical syndrome distribution law in 507 coronary heart disease patients of the Han nationality in Fuzhou city. Chin J Inter Tradit & West Med. 2011;6:756–759

AHA/ACC Guideline for the Management of Patients With Non–ST-Elevation Acute Coronary Syndromes: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guideline. J Am College Cardiol. 2014.

Guidelines for the diagnosis and treatment of chronic stable angina pectori. Chin J Cardiol. 2007;35:195–206.

Liberati A, Altman DG, Tetzlaff J, Mulrow C, Gøtzsche PC, Ioannidis JP, et al. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration. Annals Inter Med. 2009;151:W65–W94.

Higgins JPT, Green S. Cochrane handbook for systematic reviews of interventions version 5.1. 0. The Cochrane Collaboration. 2011. http://www. cochrane-handbook, org, 2013.

Clark HD, Wells GA, Huët C, et al. Assessing the quality of randomized trials: reliability of the Jadad scale. Control Clin Trials.1999;20:448–452.

Huang H, Chen G, Liao D, et al. The effects of resveratrol intervention on risk markers of cardiovascular health in overweight and obese subjects: a pooled analysis of randomized controlled trials. Obes Rev. 2016;1–12.

Liang HY. Shexiang Baoxin pills auxiliary curative effect observation of treatment of coronary heart disease angina pectoris. Contemp Med. 2010;32:133–134.

Liao XQ. Therapeutic effect compare on treatment of 45 cases of DM united with angina pectoris by Shexiang Baoxin pills and Xiaoxintong. Guiding J TCM. 2005;11:5–7.

Su JX, Zhong ZY. The effects of Shexiang Baoxin pills with combination of Iscaorbide Dinitrater tabletin treatment of angina pectoris. J Liaoning Med University. 2010;31:212–214.

Chen PL. Comparison of efficacy of Shexiang Baoxin pills and nitroglycerinin treatment of angina pectoris with coronary heart disease. J Med Forums. 2005;26:27–28.

Yu J, Gao CY, Xu WK, Pu JJ. The application of Shexiang Baoxin pill in the treatment of angina pectoris. China Prac Med. 2012;2014–16.

Guo J. Treatment efficacy of Shexiang Baoxin pill: An analysis of 80 cases coronary heart disease. Chin J Mod Drug. 2013;12(7): 28–129.

Wang DF. Treatment efficacy of Shexiang Baoxin pill: An analysis of 90 cases of coronary heart disease. China J Mod Drug. 2012;22:73–74.

Ran XH. Shexiang Baoxin Pills curative effect of stable angina: an observation study. Chin Foreign Med Treat. 2007;19:43–44.

Guo J. Treatment efficacy of Shexiang Baoxin pill: A clinical research of 40 cases coronary heart disease. Inner Mongolia Med J. 2013;26:12.

Gao WJ. Treatment efficacy of Shexiang Baoxin Pill: A clinical observation of 60 cases coronary heart disease. J Jilin Med. 2012;33:5067–5068.

Zhang YZ. 70 cases of Shexiang Baoxin Pill treating coronary heart disease angina. Chin Med Modern Distance Edu China. 2010;14:21–22.

He BL, Guo H, Yang GB, Chen YX. Clinical observation of Shexiang Baoxin Pills in treating 72 cases of coronary heart disease angina pectoris. Chin Modern Med. 2009;16:66–67.

Jiang HZ. Clinical observation of Shexiang Baoxin pills in treating 120 cases of coronary heart disease angina pectoris. Med & Health Care. 2014;2:78.

Tao HX. Clinical efficacy analysis of Shexiang Baoxin pills in treating angina. Pract Clin J Integrated Tradit Chin & West Med. 2006;6:14–15.

Ji CW. Clinical observation of Shexiang Baoxin pills in coronary heart disease angina pectoris. China’s rural health. 2014; 11:9.

Wang HM. Clinical observation of Shexiang Baoxin pills in coronary heart disease angina pectoris. Inner Mongolia Med J. 2007;39:1494–1495.

Zhang QJ. Clinical analysis of Shexiang Baoxin pills in coronary heart disease angina pectoris. China Prac Med. 2009;26: 110–111.

Li ZH. Clinical analysis and comment of Shexiang Baoxin pills in coronary heart disease angina pectoris. World Latest Med Info.2015;15:71.

Liu YQ. Clinical observation of Shexiang Baoxin pills in coronary heart disease angina pectoris. National Med Frontiers Chin. 2013;8:22–23.

Wang XH, Zhang XQ. Clinical observation of Shexiang Baoxin pills in coronary heart disease angina pectoris. J Emerg Tradit Chin Med. 2010;19:739–740.

Wang XQ. Clinical observation of Shexiang Baoxin pills in 60 cases of coronary heart disease in aged patients. Clin J Tradit Chin Med. 2005;17:20.

Zhang WW. Clinical observation of Shexiang Baoxin pills in 128 cases of coronary heart disease angina pectoris in aged patients. Chin J Med Drug. 2013;22:117–118.

Geng XY, Li XQ, Wang YB, Liao XQ. Clinical study Shexiang Baoxin pills treating senile angina pectoris patient with diabete. J Emerg Tradit Chin Med. 2006;15:348–350.

Yang MW, He XL, Liu X, Jia Y. Clinical efficacy of Shexiang Baoxin pill for elderly angina. J Liaoning University TCM. 2015;17:152–154.

Zang SH, Hu CL. Clinical Observation of Shexiang Baoxin pill for angina. J Commun Med. 2005;3:11–13.

Shao JB. Clinical Observation of Shexiang Baoxin pill for coronary heart disease angina. J North Pharm. 2015;12:56–57.

Xiang L, Jiang P, Zhan C, Chen Z, Liu X, Huang X, et al. The serum metabolomic study of intervention effects of the traditional Chinese medicine Shexiang Baoxin pill and a multi-component medicine polypill in the treatment of myocardial infarction in rats. Molecular Bio Systems. 2012;8:2434–2442.

Ignarro LJ, Lippton H, Edwards JC, Baricos WH, Hyman AL, Kadowitz PJ, et al. Mechanism of vascular smooth muscle relaxation by organic nitrates, nitrites, nitroprusside and nitric oxide: evidence for the involvement of S-nitrosothiols as active intermediates. J Pharm & Experim Therapeutics. 1981;218:739–749.


Refbacks

  • There are currently no refbacks.


Copyright (c) 2016 Journal of Pharmaceutical and Biomedical Sciences

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.